Search by Drug Name or NDC
NDC 76420-0540-05 Lidocaine Hydrochloride 20 mg/mL Details
Lidocaine Hydrochloride 20 mg/mL
Lidocaine Hydrochloride is a EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Asclemed USA, Inc.. The primary component is LIDOCAINE HYDROCHLORIDE.
Product Information
| NDC | 76420-0540 |
|---|---|
| Product ID | 76420-540_f5e688fe-a3a6-70a5-e053-2a95a90a2889 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Lidocaine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lidocaine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/mL |
| Substance Name | LIDOCAINE HYDROCHLORIDE |
| Labeler Name | Asclemed USA, Inc. |
| Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203082 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 76420-0540-05 (76420054005)
| NDC Package Code | 76420-540-05 |
|---|---|
| Billing NDC | 76420054005 |
| Package | 5 mL in 1 VIAL, SINGLE-DOSE (76420-540-05) |
| Marketing Start Date | 2023-03-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |